Lip implant
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 5 March 2024, 2.6 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
47 claims: 10 independent, 37 dependent
- 1Claims of equivalent WO 2004080337 A2 WHAT IS CLAIMED IS:1. A lip implant, comprising: solid silicone shaped to conespond to the shape of a lip.
- 10A lip implant, comprising:solid silicone, comprising a middle portion having a substantially uniform diameter between 2 millimeters and 10 millimeters;a pair of end portions having a tapered diameter;a durometer rating between 5 and 10;and a length between 5 centimeters and 8 centimeters.
- 11A lip instrument for use in implanting a lip implant, comprising:a pair of arms coupled together via a pivot means wherein the arms each comprise a clamping member facing the other clamping member, the clamping members shaped to hold the lip implant.
- 15A method for inserting a lip implant into a lip of a patient, comprising:forming a first incision on one side of the lip and a second incision on another side of the lip;forming a urnnel from the first incision to the second incision;inserting a lip instrument into the first incision and the tonnel such that a portion of the lip instrument extends through the second incision;grasping the lip implant with the lip instrument;drawing the lip implant into the tunnel;and releasing the lip implant.
- 16A lip implant, comprising:a first region being formed of liquid material;and a second region surrounding the first region, the second region being composed of a solid material;wherein the entirety of the implant is generally shaped to correspond to the shape of a lip.
- 26A hp implant, comprising:a first region being formed of a material having a first durometer rating;and a second region surrounding the first region, the second region being formed of a material having a second durometer rating, the second durometer rating being higher than the first durometer rating;wherein the entirety of the implant is generally shaped to correspond to the shape of a lip.
- 32A lip implant, comprising:solid silicone shaped for insertion into a lip, the solid silicone having an elongated cross-section, the cross-section being substantially uniform along the length of the solid silicone.
- 33A lip implant, comprising:solid urethane in any shape suitable for implantation in a lip.
- 39A lip implant, comprising:a first region comprising gas;and a second region surrounding the first region, the second region being formed of a solid material;wherein the entirety of the lip implant is in a shape suitable for augmentation in a lip.
- 47A method for inserting a lip implant into a lip, comprising:providing solid silicone implants shaped to have an elongated cross-section, the cross- section being substantially uniform along the length of the solid silicone;inserting the solid silicone into a lip;and forming the solid silicone into a shape conesponding to the shape of a lip.
Independent claims10
48 paragraphs, as filed
Description of equivalent WO 2004080337 A2
LIP IMPLANT AND METHOD FOR INSERTION Background
The present disclosure relates generally to a lip implant, and more particularly to a lip implant, which may be used for lip augmentation or enhancement. Within the field of Plastic Surgery, soft tissue augmentation has long been in popular demand by people wishing to enhance their physical appearance. More recently, lip augmentation, i.e. increasing the fullness of the lips, has become a viable entity.
Currently, there are a variety of materials and methods used for lip augmentation.
Some of the current techniques provide for temporary lip augmentation via injection of various materials into the lip such as fat, collagen, hyaluronic acid, and particulated dermis or fascia.
One of the disadvantages of such temporary techniques is the need for the patient to periodically undergo additional procedures to maintain the lip fullness.
Other techniques, such as liquid silicone injections, provide a more permanent lip augmentation. However, liquid silicone injections may be complicated by skin ulceration, long-term nodularity and granuloma formation, and chronic cellulitis. Furthermore, it is inherently difficult to remove liquid silicone from the lips should a problem arise or should the patient desire removal. That is, reversibility is difficult or impossible.
Another permanent lip augmentation technique is the implantation of expanded polytetraflouroethylene (PTFE) such as Gore-Tex® strips or tubular forms of PTFE such as Softform® and Ultrasoft™. Expanded PTFE utilizes the concept of tissue ingrowth into the porous wall of the implant. While beneficial in some areas of the body, implantation of such material into the lips can be complicated by tissue adherence to the implant. Tissue ingrowth may result in restriction of lip excursion and result in an abnormal appearance during facial expression. Furthermore, fluid may accumulate inside the tubular forms of PTFE, thereby resulting in an unacceptable incidence of postoperative surgical infection and subsequent loss of implant.
Therefore, what is needed is a lip implant that eliminates, or at least significantly reduces, the above-described complications. Moreover, instrumentation and a method for insertion of this new lip implant are needed. Finally, a method that is easily reversible is needed. Brief Description of the Drawings
Fig. 1 is a perspective view of a lip implant according to one embodiment of the present disclosure.
Fig. 2 is a cross-sectional view of the lip implant of Fig. 1 taken along the line 2-2. Fig. 3 is a perspective view of a lip implant instrument according to one embodiment of the present disclosure.
Fig. 4 is a side view of the lip implant instrument of Fig. 3.
Fig. 5 is a cross-sectional view of the lip implant instrument of Fig. 4 taken along the line 5-5. Fig. 6 is a schematic view of a lip for receiving the lip implant according to the present disclosure.
Fig. 7 is a perspective view of a lip implant according to another embodiment of the present disclosure.
Fig. 8 is a perspective view of a lip implant according to yet another embodiment of the present disclosure.
Fig. 9 is a perspective view of a lip implant according to yet another embodiment of the present disclosure.
Fig. 10 is a perspective view of a lip implant according to yet another embodiment of the present disclosure. Fig. 11 a is a sectional view of a lip implant according to yet another embodiment of the present disclosure.
Fig. 1 lb is a sectional view of a lip implant according to yet another embodiment of the present disclosure.
Fig. 1 lc is a sectional view of a lip implant according to yet another embodiment of the present disclosure.
Description
Referring to Fig. 1, a lip implant for implantation into a lip of a patient (not shown) is generally referred to by reference numeral 10. h one embodiment, the lip implant is integrally formed of medical grade silicone and is substantially solid as shown in the cross-section of
Fig. 2. The implant can be manufactured by a variety of methods including, but not limited to, injection molding, cast molding, extrusion, or cutting from a larger, solid block. The lip implant 10 is formed to have a substantially uniform level of hardness as can be measured by the durometer A-scale rating. Of course, hardness can be measured in manners other than via durometer A-scale ratings, i one embodiment, the lip implant 10 has a durometer rating of ten (10) or less resulting in a relatively soft lip implant. In such an embodiment, the lip implant 10 may include a skin 12, also formed of silicone, having a higher durometer rating to provide the lip implant with structural integrity and manageability. Accordingly, the provision of the skin 12 may aid in handling or manageability of the lip implant 10. However, the provision for a skin 12 is not always necessary, and the lip implant 10 with a durometer rating often (10) or less may be used without the need for an external skin. Of course, the particular durometer rating of the lip implant 10 may vary depending on the particular firmness desired. Also, the lip implant 10 may have a varying durometer rating of 0 to 50, resulting in a lip implant having a non-uniform hardness.
The lip implant 10 is shaped to have a substantially circular cross-section (Fig.2). The diameter of the lip implant 10 is substantially uniform along the longitudinal axis of amiddle portion 14 of the lip implant. The diameter of the middle portion 14 of the lip implant 10 can vary depending on the desired thickness of the lip implant. For instance, the diameter of the lip implant 10 maybe between 2-10 millimeters.
The middle portion 14 of the lip implant 10 defines a pair of end portions 16. The end portions 16 are tapered in diameter such that the diameter of the lip implant 10 along the end portions decreases from the middle portion 14 to the ends of the lip implant. The middle portion 14 and the end portions 16 of the lip implant 10 cooperate to define the length of the lip implant, which can vary depending on the desired length of the lip implant. For instance, the length of the lip implant 10 maybe between 5-8 centimeters.
Referring to Figs. 3-5, a lip instrument for use in implanting the lip implant 10 is generally referred to by reference numeral 20. The lip instrument 20 includes a pair of arms 22a, 22b coupled together at a pivot point 24 in any conventional manner to provide for relative pivotal movement of the arms about a pivotal axis P (Fig. 4). Proximal to the pivotal axis P, the arms 22a, 22b include a pair of integrally formed ring-like members 26a, 26b, respectively, which define a pair of finger openings 28a, 28b. A pair of protrusions 30a, 30b extend towards one another from the ring-like members 26a, 26b, respectively, to prevent over-rotation of the arms 22a, 22b. Distal to the pivotal axis P, the arms 22a, 22b include a pair of integrally formed curved clamping members 32a, 32b, respectively, which cooperate to grasp the lip implant 10
(Fig. 1) as will be further described with respect to the method of insertion. Refeπing to Fig.
5, the clamping members 32a, 32b include an outer generally convex surface 34a, 34b, respectively, and a corresponding inner generally concave surface 36a, 36b.
The inner surfaces 36a, 36b of the clamping members 32a, 32b face one another such that closing of the clamping members defines a generally circular area for grasping the lip implant 10 (Fig. 1). The inner surfaces 36a, 36b are formed ofa non-crushing surface in order to prevent damage to the lip implant 10 (Fig. 1) when squeezed between the clamping members, i one embodiment, the inner surfaces 36a, 36b are formed of carbide.
Referring to Fig. 6, a lip region 40 of a patient (not shown) to receive the lip implant is depicted. The lip region 40 includes an upper lip 42 and a lower lip 44, which meet at a pair of commissures 46a, 46b. The commissures 46a, 46b are substantially equidistant from a midline
M of the lip region 40. A tunnel 48, as is generally illustrated in phantom in Fig. 6, is formed through the lower lip 44 for reasons to be described with respect to the method for insertion.
Method for Insertion hi operation, referring to Fig. 6, the lip region 40 is prepared for insertion of the implant by administering a local or regional anesthetic. Incisions are then made at each commissure 46a, 46b of the lip region 40 via a conventional scalpel or scissors. For sake of clarity, the method of insertion will be described with respect to insertion of the lip implant 10 into the lower lip 44 although it will be understood that the lip implant can be inserted into the upper lip 42 as well.
Initial formation of the tunnel 48 is then performed with conventional curved iris scissors (not shown). The iris scissors are inserted into the lower lip 44 via the incision at commissure 46a to dissect the tunnel 48 towards the midline M of the lip region 40. hi a like manner, the iris scissors are then inserted through the incision at commissure 46b on the opposite side of the lip region 40 to dissect the tunnel 48 towards the midline M of the lip region. Such dissection culminates in the initial formation of the tunnel 48 through the lower lip 44. The tunnel 48 is then widened via manipulation of the iris scissors or lip instrument 20 to complete the foraiation of the tunnel. After establishing the tunnel 48, the lip instrument 20 is inserted into the lower lip 44 via the incision at commissure 46a and the tar-nel 48 such that the clamping members 32a, 32b extend through the tunnel enabling a portion of the clamping members to extend outside of the incision at commissure 46b. The lip instrument 20 is then actuated to grasp the lip implant 10 between the clamping members 32a, 32b. The lip implant 10 is then drawn into the lower lip 44 via the lip instrument 20 until it is positioned appropriately within the tunnel 48 whereupon the lip implant is released from the lip instrument.
A conventional suture, such as a chromic or nylon suture, is then used to close the incisions at commissures 46a, 46b. Antibiotic ointment may be applied to the incisions at commissures 46a, 46b as a prophylaxis against infection. Ice may be applied indirectly to the lip region 40 to reduce swelling.
Thus, as described, insertion of the lip implant 10 is accomplished simply and quickly and in an uninterrupted manner. Thus, many of the problems associated with previous lip augmentation techniques can be eliminated with the use of the lip implant 10. Furthermore, this process is completely reversible if desired.
Alternates and Equivalents
It is understood that a variety of alternative lip implants are contemplated by this disclosure. For example, and referring now to Fig. 7, a lip implant 70 substantially similar in all respects to the lip implant 10 of Figs. 1 and 2, other than those features described below, has a middle portion 72 that includes a section 74 having a non-uniform diameter. another alternative embodiment, and referring now to Fig. 8, a lip implant 80 substantially similar in all respects to the lip implant 10 of Figs. 1 and 2, other than those features described below, includes a middle portion 82 having a non-uniform diameter along the entire length of the middle portion.
In yet another alternative embodiment, and referring now to Fig. 9, a lip implant 90 substantially similar in all respects to the lip implant 10 of Figs. 1 and 2, other than those features described below, is substantially non-uniform in diameter along the length of the implant. The lip implant 90 is reduced in diameter at a middle portion 92 thereof. In operation, the lip implants 70, 80 and 90 of Figs. 7, 8 and 9, respectively, are inserted into the lower lip 44 (Fig. 6) of the patient in a substantially similar manner as described above. Thus, the embodiments of Figs. 7, 8 and 9 enjoy the advantages of that of Fig. 1 with respect to providing a structurally sound and safe lip implant for lip augmentation purposes.
In yet another alternative embodiment, and referring now to Fig. 10, an alternative lip implant 100 substantially similar in all respects to the lip implant 10 of Figs. 1 and 2, other than those features described below, is shaped to have a substantially elongated cross-section, which is substantially unifonn in size along the length of the implant, h operation, the lip implant 100 is inserted into the lower lip 44 (Fig. 6) of the patient in a substantially similar manner as described above. After insertion into the lower lip 44, the lip implant 100 may be further sized to correspond to the shape of the lip. For example, the ends of the lip implant 100 may be cut in a tapered fashion such that the lip implant is customized to the particular shapes and contours of the lower lip 44.
As can be appreciated, the materials used in forming the lip implants of the present disclosure can be varied to include additional materials for use with silicone or alternative materials other than silicone. For example, the lip implants 10, 70, 80, 90, 100 and other embodiments of the lip implant of the present disclosure may alternatively be formed of urethane rather than silicone.
Moreover, referring to Fig. 1 la, an alternative lip implant 110a includes an inner core region 112a formed of expanded polytetraflouroethylene (PTFE) such as Gore-Tex®, and an outer shell 114a formed of silicone. The silicone used for the outer shell 114a provides the lip implant 110a with additional manageability. More importantly, the presence of the outer silicone shell 114a aids in preventing tissue-adherence associated with the use of expanded PTFE.
It is understood that other types of outer shells are contemplated for the lip implant 110. For example, in some embodiments, the outer shell 114a may be in the form of apolymer coating, such as Parylene , which can be applied to the exterior of the inner core region 112a to provide structural integrity and manageability. Accordingly, any number of materials including but not limited to silicone, urethane, expanded PTFE, and biocompatible polymers, and any combination of such materials may be used to form the lip implant 110a.
In another embodiment, and referring to Fig. lib, an alternative lip implant 110b includes an inner core region 112b formed of materials such as liquid silicone, silicone gel or beads, cohesive silicone gel or beads, biocompatible oil, saline or a biocompatible hydrogel material. The lip implant 110b further includes an outer shell 114b, which may be formed of a variety of materials including but not limited to silicone, urethane and biocompatible polymer (such as Parylene™). As can be appreciated, the outer shell 114b encloses the inner core region 112b and may be formed in an impermeable or semipermeable manner such that there is minimal or no leakage of the inner core region 112b through the outer shell. In still other embodiments, and refening to Fig. 1 lc, an alternative lip implant 110c includes an inner core region 112c, which may take the form of a hollow space defined by an outer shell 114c. In such an embodiment, the inner core region 112c can be filled with a gas such as air. Moreover, the outer shell 114c maybe formed of a variety of materials including but not limited to silicone, urethane and biocompatible polymers. As can be appreciated, the outer shell 104c may be formed in an impermeable manner such that there is no leakage of gas from the inner core region 112c through the outer shell.
While the invention has been particularly shown and described with reference to embodiments thereof, it is understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention. For example, although a plurality of shapes of the lip implant 10 is described, these shapes are merely representative of the variety of shapes that the lip implant may take. Thus, the lip implant 10 is not limited to the longitudinal or cross-sectional shapes as described.
Moreover, the tapered end portions 16 of the lip implant 10 may be removed resulting in a lip implant having a rod-like shape. Still further, the degree of taper and the length of the end portions 16 may be varied to accommodate the various desires or needs of implant patients.
Still further, the clamping members 32a, 32b of the lip instrument 20 may be removable attached to the lip instrument such that various other clamping members may be used therewith. For instance, various degrees of curvature may be required of the clamping members resulting in the need to interchange the clamping members.
Furthermore, the inner surfaces 36a, 36b of the clamping members 32a, 32b maybe formed of a variety of materials other than carbide.
Still further, during insertion of the lip implant 10 into the lower lip 44, the incision may be made in the general commissure region on each side of the lip region 40 and such insertion is not limited to an exact commissure point.
It is also understood that all spatial references, such as "diameter", "longitudinal," "increase," and "decrease" are for illustrative purposes only and can be varied within the scope of the invention. Accordingly, all such modifications are intended to be included within the scope of this invention as defined in the following claims.
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO0033771A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| US4157085A | Cites | United States of America | Search report |
| DE4414103A1 | Cites | Germany | Search report |
| US6277150B1 | Cites | United States of America | Search report |
| WO9534256A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WO9951164A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
38 members in 10 offices
Priority claims9
| Document | Office | Kind | Date |
|---|---|---|---|
| 384229 | United States of America | – | |
| 38422903 | United States of America | A | |
| 38422903 | United States of America | A | |
| 2004006722 | United States of America | W | |
| 2004006722 | United States of America | W | |
| 384229 | – | – | – |
| US20030384229 | – | – | – |
| US2004006722 | – | – | – |
| WO2004US06722 | – | – | – |
Members38
| Document | Office | Kind | |
|---|---|---|---|
| US2004176856A1 | United States of America | A1 | |
| AU2004220602A1 | Australia | A1 | |
| CA2516696A1 | Canada | A1 | |
| WO2004080337A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2004080337A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2005177234A1 | United States of America | A1 | |
| EP1608291A2This record | European Patent Office (EPO) | A2 | |
| US2006025867A1 | United States of America | A1 | |
| MXPA05009527A | Mexico | A | |
| MXPA05009527A | Mexico | A | |
| BRPI0408126A | Brazil | A | |
| BRPI0408126A | Brazil | A | |
| US7008455B2 | United States of America | B2 | |
| US7329286B2 | United States of America | B2 | |
| US2008058928A1 | United States of America | A1 | |
| US7344566B2 | United States of America | B2 | |
| EP1608291A4 | European Patent Office (EPO) | A4 | |
| AU2004220602B2 | Australia | B2 | |
| EP1608291B1 | European Patent Office (EPO) | B1 | |
| AT499904T | Austria | T | |
| ATE499904T1 | Austria | T1 | |
| DE602004031595D1 | Germany | D1 | |
| EP2335646A2 | European Patent Office (EPO) | A2 | |
| ES2362213T3 | Spain | T3 | |
| US7993409B2 | United States of America | B2 | |
| US2011264215A1 | United States of America | A1 | |
| EP2335646A3 | European Patent Office (EPO) | A3 | |
| EP2417932A1 | European Patent Office (EPO) | A1 | |
| EP2335646B1 | European Patent Office (EPO) | B1 | |
| ES2400289T3 | Spain | T3 | |
| EP2417932B1 | European Patent Office (EPO) | B1 | |
| ES2422560T3 | Spain | T3 | |
| CA2516696C | Canada | C | |
| BRPI0408126B1 | Brazil | B1 | |
| BRPI0408126B8 | Brazil | B8 | |
| USD979060S | United States of America | S | |
| USD1040348S | United States of America | S | |
| USD1114255S | United States of America | S |
85 legal events, as 10 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Opt-out of the competence of the unified patent court (upc) registeredP01 | P01 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Fee paymentPLFP | PLFP | FR | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Patent lapsed due to non-payment of maintenance feesLapsedMM4A | MM4A | SK | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Lapsed because of non-payment of the annual feeLapsedV1 | V1 | NL | |
| Be: lapsedLapsedBERE | BERE | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Filing of the translation of the text of european patentsAG4A | AG4A | HU | |
| Translation of european patent specification into slovakT3 | T3 | SK | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Name/firm changedPFA | PFA | CH | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Party data changed (patent owner data changed or rights of a patent transferred)RAP2 | RAP2 | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| New agentNV | NV | CH | |
| Translation filed for an european patent granted for nl, confirming art. 52 par. 1 or 6 of the patents act 1995GrantedT3 | T3 | NL | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| Corresponds to:REF | REF | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Title (correction)LIP IMPLANTRTI1 | RTI1 | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 1608291
- Publication, DOCDB
- 1608291
- Publication, EPODOC
- EP1608291
- Application
- 4717985
- Application, DOCDB
- 04717985
- Application, EPODOC
- EP20040717985
Titles3
- German
- LIPPENIMPLANTAT UND EINSATZVERFAHREN
- English
- LIP IMPLANT AND METHOD FOR INSERTION
- French
- IMPLANT LABIAL ET PROCEDE D'INSERTION
Classification
- CPC, 6
- A61F2/0059
- A61B17/282
- A61B17/3468
- A61B2017/00792
- A61F2/02
- A61F2250/0019
- IPC, 2
- A61B17 28
- A61B17 34
Designated states2
- Contracting states, 1
- Türkiye
- Extension states, 1
- North Macedonia